Evidence and findings
Fifty-eight adults with type 2 diabetes were randomized to alpha-tocopherol, mixed tocopherols or placebo for six weeks. Investigators measured ambulatory blood pressure, heart rate, vascular function and oxidation markers. [1]
Both tocopherol regimens increased systolic and diastolic pressure compared with placebo. Plasma F2-isoprostanes decreased, while urinary measures and vascular-dilation outcomes did not show corresponding benefit. [1]
Interpretation and limits
These were particular high-dose preparations in a selected population, not ordinary food intake. Other trials and settings may differ. Funding and conflicts were not established from the abstract; the result shows why a biomarker cannot replace direct assessment of the outcome being claimed. [1]
A hypothetical distinction
Imagine a supplement improves one laboratory marker while a clinically relevant measurement worsens. Reporting only the favorable marker would conceal the tradeoff.
| Detail | Interpretation |
|---|---|
| Oxidation marker | One biological measurement |
| Blood pressure | Separate outcome |
| Food intake | Different exposure |
Sources for this article
- The effect of vitamin E on blood pressure in individuals with type 2 diabetes: a randomized, double-blind, placebo-controlled trial - PubMed
Source consulted: 2026-09-19. This is a reference resource, not a claim that we conducted the studies or tested a product.